Fallopian Tube Carcinoma

Explore clinical trials studying Fallopian Tube Carcinoma. Study availability and eligibility vary by location and protocol.

47 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Fallopian Tube Carcinoma trial results

Active, Not Recruiting

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

NCT02345265

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions: Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations: Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States

Thomas Hospital Fairhope, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States

View all 150 locations

View Trial Details

Active, Not Recruiting

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

NCT05763199

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Active, Not Recruiting

Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

NCT04204811

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer

NCT05406674

Conditions: Adnexal Diseases, FIGO Stage III Ovarian Cancer, Fallopian Tube Carcinoma, +12 more
Locations: Antoni van Leeuwenhoek (NKI-AVL) Amsterdam, Netherlands

UMCU Utrecht, Netherlands

View Trial Details

Active, Not Recruiting

NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma

NCT06972693

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Istituto Europeo di Oncologia Milan, Italy

View Trial Details

Active, Not Recruiting

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations: Mercy Medical Center Baltimore, Maryland, United States

View Trial Details

Fallopian Tube Carcinoma

Fallopian Tube Carcinoma trial results

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

National Cancer Institute "Cancer Moonshot Biobank"

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer

NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma

HOT: HIPEC in Ovarian Cancer as Initial Treatment

Related conditions